Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruption

Donn J. Colby, Michal Sarnecki, Dan H. Barouch, Somporn Tipsuk, Daniel J. Stieh, Eugène Kroon, Alexandra Schuetz, Jintana Intasan, Carlo Sacdalan, Suteeraporn Pinyakorn, Pornsuk Grandin, Hongshuo Song, Sodsai Tovanabutra, Zhanna Shubin, Dohoon Kim, Dominic Paquin-Proulx, Michael A. Eller, Rasmi Thomas, Mark de Souza, Lindsay WieczorekVictoria R. Polonis, Amélie Pagliuzza, Nicolas Chomont, Lauren Peter, Joseph P. Nkolola, Johan Vingerhoets, Carla Truyers, Maria G. Pau, Hanneke Schuitemaker, Nittaya Phanuphak, Nelson Michael, Merlin L. Robb*, Frank L. Tomaka, Jintanat Ananworanich

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

49 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruption'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry